Novo Nordisk's shares plummeted due to disappointing trial results for CagriSema, with patients achieving only 22.7% weight ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo Nordisk and Valo Health have expanded their agreement to discover and develop new treatments for type 2 diabetes, ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...

New data suggest Restylane Lyft or Contour in combination with Sculptra corrects contour deficiencies in patients experiencing facial volume loss following medication-driven weight loss, according to ...

Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...

Denmark's Prime Minister Mette Frederiksen has called the country's business leaders to a meeting on Thursday after U.S.

Danish businesses are concerned about a possible trade conflict with the United States over Greenland, a major lobby group ...

The Korean unit of Danish health care giant Novo Nordisk signed a memorandum of understanding with Seoul National University Bundang Hospital to cooperate on chronic disorder trials and research.

Massachusetts is the latest state going after insulin makers and the intermediaries officials accuse of price gouging. Why it ...

In diabetic kidney disease, fat accumulates in the kidneys, leading to lipotoxicity and kidney damage. A recently published ...